The exploration of advanced neuropsychiatric treatments and interventional mental health care has accelerated rapidly across the globe. Across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, individuals seeking relief from treatment-resistant conditions frequently inquire about the availability, legal acquisition, and clinical administration of ketamine. For those […]